Results from a phase 3 clinical trial provide new insights into management of patients with mCRPC 🩺 Abstract: LBA1, Proffered Paper Discover more: https://lnkd.in/eytECTz8
Great news for advanced metastatic prostate cancer patients. Highest OS of any study in mCRPC- truly awesome!
Great achievement and very meaningful for those patients suffering from mCRPC!
Congrats to the team!
MD | Healthcare Leader | Expertise in Medical, Commercial & Market Access | Launch Excellence & Cross-functional Collaboration
2moNever underestimate great old, but unique product!